Subscribe To
Predictive oncology reports 45% revenue jump, increased gross profit margin in 3q
Predictive Oncology Inc. (NASDAQ:POAI) has reported revenue growth and an increased gross profit margin in its third quarter as the company continues ...
November 11, 2022, 9:04 am
Hillevax to participate in november investor conferences
BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerci...
November 10, 2022, 6:30 pm
Bicycle therapeutics to present five posters highlighting preclinical data from its bicycle tumor-targeted immune cell agonist® (bicycle tica®) programs at the sitc 37th annual meeting
CAMBRIDGE, England, & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated cla...
November 10, 2022, 9:09 am
Seqll provides third quarter 2022 financial results
BILLERICA, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providin...
November 10, 2022, 3:08 am
Veru provides update on fda advisory committee meeting regarding emergency use authorization of sabizabulin to treat hospitalized covid-19 patients at high risk for acute respiratory distress syndrome
MIAMI, FL, Nov. 09, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing ...
November 10, 2022, 1:55 am
Vectivbio to present at the 2022 jefferies london healthcare conference
BASEL, Switzerland, Nov. 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical compan...
November 9, 2022, 8:28 am
Atreca to present at upcoming investor conferences
SAN CARLOS, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developi...
November 7, 2022, 4:30 pm
Virios therapeutics to report third quarter 2022 financial results and provide corporate update on monday, november 14, 2022
ATLANTA--(BUSINESS WIRE)---- $VIRI #Biotech--Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing ...
November 3, 2022, 7:05 am
Axsome therapeutics: all eyes on auvelity launch
Shares of Axsome Therapeutics have posted a 30% gain so far in 2022. There's a sizeable niche and unmet need in the MDD market that Auvelity could add...
November 2, 2022, 5:30 pm
Biomx to present at h.c. wainwright 24th annual global investment conference
NESS ZIONA, Israel--(BUSINESS WIRE)--BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancin...
September 11, 2022, 7:22 am
Ultragenyx and mereo biopharma to present setrusumab data update at asbmr
NOVATO, Calif. and MOUNTAIN VIEW, Calif. and LONDON, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), (“Ultragenyx�...
September 9, 2022, 8:22 pm
Atreca to present at upcoming investor conferences
SAN CARLOS, Calif., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on develop...
September 9, 2022, 4:05 pm
Catalyst pharmaceuticals to participate in the h.c. wainwright 24th annual global investment conference
CORAL GABLES, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutica...
September 9, 2022, 8:03 am
Lobe sciences secures $1.3m private placement to fund advancement of its brain trauma-treating psilocin analogs
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it has closed a non-brokered private placement of units for gross proceeds of more than $1.3 million t...
September 8, 2022, 3:29 pm
Mindset pharma files 16 national patent applications to protect family of novel next-generation psychedelics
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said it has filed 16 national patent applications, including in the principal South East Asian markets to p...
September 7, 2022, 9:04 am
Phathom pharmaceuticals to present at the h.c. wainwright 24th annual global investment conference
FLORHAM PARK, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
September 7, 2022, 8:15 am
Ortho regenerative technologies announces name change to chitogenx
Ortho Regenerative Technologies Inc (CSE:ORTH) announced that it has changed its corporate name to ChitogenX Inc to better reflect the company's expan...
September 7, 2022, 7:46 am
Box upgrades e-signature capability with innovative features
BOX enhances Box Sign with novel features to help Box customers optimally use the Box content cloud wit...
September 2, 2022, 5:18 pm
3 vertical farming stocks to buy for big growth
Vertical farming may answer the question of how to feed a growing population amid increasingly unpredictable weather conditions due to climate change....
September 1, 2022, 6:02 pm
Hillevax to participate in j.p. morgan biotech – 2022 conference call series
BOSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commerc...
September 1, 2022, 5:18 pm